126 related articles for article (PubMed ID: 34893342)
1. Reactivity characterization of bromoacetyl derivatized polyribosylribitol polysaccharide in Haemophilus influenzae type b for PedvaxHIB® by NMR spectroscopy.
Rustandi RR; Xu Q
Vaccine; 2022 Jan; 40(2):187-191. PubMed ID: 34893342
[TBL] [Abstract][Full Text] [Related]
2. Monitoring bromide loss in bromoacetyl-derivatized polyribosylribitol polysaccharide in Haemophilus influenzae type b for PedvaxHIB® by capillary electrophoresis and NMR spectroscopy.
Rustandi RR; Hamm M; Onimus M; Yuan Y; Anderson CL; Zong C
Vaccine; 2022 Oct; 40(42):6012-6016. PubMed ID: 36123258
[TBL] [Abstract][Full Text] [Related]
3. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
Dashefsky B; Wald E; Guerra N; Byers C
Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
[TBL] [Abstract][Full Text] [Related]
4. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data.
Heath PT
Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S117-22. PubMed ID: 9781743
[TBL] [Abstract][Full Text] [Related]
5. Quantitative nuclear magnetic resonance analysis and characterization of the derivatized Haemophilus influenzae type b polysaccharide intermediate for PedvaxHIB.
Xu Q; Klees J; Teyral J; Capen R; Huang M; Sturgess AW; Hennessey JP; Washabaugh M; Sitrin R; Abeygunawardana C
Anal Biochem; 2005 Feb; 337(2):235-45. PubMed ID: 15691503
[TBL] [Abstract][Full Text] [Related]
6. An enzyme-linked immunosorbent assay for quantitation of Haemophilus Influenzae type b polysaccharide-specific IgG1 and IgG2 in human and infant rhesus monkey sera.
Dolan KT; Staub JM; Schofield TL; Ahonkhai VI; Ellis RW; Vella PP
J Immunoassay; 1991; 12(4):543-64. PubMed ID: 1806588
[TBL] [Abstract][Full Text] [Related]
7. Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharide.
Jelonek MT; Chang SJ; Chiu CY; Park MK; Nahm MH; Ward JI
Infect Immun; 1993 Dec; 61(12):5345-50. PubMed ID: 8225608
[TBL] [Abstract][Full Text] [Related]
8. Postlicensure effectiveness of the Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer-membrane protein complex conjugate vaccine among Navajo children.
Harrison LH; Tajkowski C; Croll J; Reid R; Hu D; Brenneman G; Weatherholtz RC; Santosham M
J Pediatr; 1994 Oct; 125(4):571-6. PubMed ID: 7931875
[TBL] [Abstract][Full Text] [Related]
9. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
Sood SK; Daum RS
Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
[TBL] [Abstract][Full Text] [Related]
10. Opsonophagocidal activity in sera from infants and children immunized with Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate).
Gray BM
Pediatrics; 1990 Apr; 85(4 Pt 2):694-7. PubMed ID: 2107521
[TBL] [Abstract][Full Text] [Related]
11. Haemophilus influenzae type b capsular polysaccharide antibody levels in Japanese young patients with hematological malignancies and asplenia.
Takeshita K; Ishiwada N; Takeuchi N; Takahashi Y; Fukasawa C; Hishiki H; Hoshino T; Shimojo N
J Infect Chemother; 2020 Sep; 26(9):959-962. PubMed ID: 32402734
[TBL] [Abstract][Full Text] [Related]
12. Reemergence of invasive Haemophilus influenzae type b disease in Alaska: Is it because of vaccination with polyribosylribitol phosphate outer membrane protein complex (PRP-OMPC) or failure to vaccinate with PRP-OMPC?
Dargan JM; Coplan PM; Kaplan KM; Nikas A
J Infect Dis; 2000 Feb; 181(2):806-9. PubMed ID: 10669389
[No Abstract] [Full Text] [Related]
13. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of Haemophilus influenzae type b conjugate vaccine (PedvaxHIB) in Papua New Guinean children.
Lehmann D; Kakazo M; Yarsley S; Javati A; Taime J; Saleu G; Namuigi P; Alpers MP; Mendelman PM; Staub T
P N G Med J; 1998; 41(3-4):102-11. PubMed ID: 10934551
[TBL] [Abstract][Full Text] [Related]
15. Prevention of Haemophilus influenzae type b disease.
Santosham M
Vaccine; 1993; 11 Suppl 1():S52-7. PubMed ID: 8447177
[TBL] [Abstract][Full Text] [Related]
16. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine.
Donnelly JJ; Deck RR; Liu MA
J Immunol; 1990 Nov; 145(9):3071-9. PubMed ID: 2120344
[TBL] [Abstract][Full Text] [Related]
18. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.
Schlesinger Y; Granoff DM
JAMA; 1992 Mar; 267(11):1489-94. PubMed ID: 1538539
[TBL] [Abstract][Full Text] [Related]
19. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
[TBL] [Abstract][Full Text] [Related]
20. Haemophilus influenzae type b conjugate vaccine stability: catalytic depolymerization of PRP in the presence of aluminum hydroxide.
Sturgess AW; Rush K; Charbonneau RJ; Lee JI; West DJ; Sitrin RD; Hennessy JP
Vaccine; 1999 Mar; 17(9-10):1169-78. PubMed ID: 10195629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]